E-mail Print PDF

Research Use

suPAR’s powerful prognostic value has been exemplified over the last 10 years in more than 130 publications on various disease conditions including SIRS/sepsis, HIV, TB, cancer, malaria and meningitis. Past research strongly corroborates that high suPAR levels reflect increased inflammation and/or critical immune activation.

Thus suPAR can be used to triage patient samples, measure treatment response and further document reached endpoints. suPAR's high stability and uniform kinetics make it a reliable clinical biomarker – it beats other markers used for similar purposes.

 

suPARnostic® is a top-line product line for measurement of suPAR in human plasma, serum, urine and other sample types. Since its commercial introduction in 2008, suPARnostic® has been used and adopted by medical doctors and researchers in Europe, Asia and Africa working in a variety of diseases including SIRS, TB and HIV, inflammation CV conditions, etc.

 

suPARnostic® Broadens Your Research Project:

  • Valuable information about progression of several infectious diseases (e.g. sepsis/SIRS, meningitis, TB, HIV, malaria) and cancer
  • Monitoring tool for treatment response
  • Tool for stratification of study populations for homogenous background, confirmation of endpoints
  • Reliable risk status marker predicting mortality risk, stronger than SAPSII and SOFA score
  • Status markerof the immune system and immune activation
  • Reproducible and increased prognostic value compared to other known markers

For more information about suPAR Research, please read here:

fact sheet supar research.pdf fact sheet supar research.pdf (496.40 KB) 


 

 

News

suPARnostic® test now part of screening program at Hvidovre University Hospital

Novel screening program prevents admissions to the hospital.... 

 

suPARnostic® partnered with new distributors in France, India and Ireland....     


 

"suPAR - en helt ny måde at tænke sygdom på"
Read the article in the magazine Praksis.....                                                           

 

"Dansk opfindelse kan fange sygdomssignaler i opløbet"
Read the article from Opfinderrådgivningen, Teknologisk Institut...                                                                    

 

ViroGates launches suPARnostic® Quick Triage product
Read more about this new marker for the emergency room
....                                                                                 

 


Follow suPAR on Twitter:

suPARnostic®

Find suPAR on LinkedIn:

suPARnostic®